Wikidata

(Q53599441)

English

A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.

scientific article

In more languages

Statements

title
A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16972242
retrieved
16 May 2018
reference URL
http://europepmc.org/abstract/MED/16972242

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53599441&oldid=1245977429"